Aratana Therapeutics Inc (PETX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Steven St. Peter
Employees:
79
11400 TOMAHAWK CREEK PARKWAY, SUITE 340, LEAWOOD, KS 66211
913.353.1000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Aratana Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics. It delivers innovative prescription medicines that address significant medical needs for cats and dogs. The company licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. Aratana Therapeutics was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.

Data derived from most recent annual or quarterly report
Market Cap 240.932 Million Shares Outstanding48.97 Million Avg 30-day Volume 1.077 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.27
Price to Revenue4.5519 Debt to Equity0.0 EBITDA-10.592 Million
Price to Book Value1.8322 Operating Margin-28.4464 Enterprise Value139.233 Million
Current Ratio6.66 EPS Growth0.735 Quick Ratio5.177
1 Yr BETA 0.8626 52-week High/Low 0.0 / Profit Margin-33.4659
Operating Cash Flow Growth89.2668 Altman Z-Score9.6812 Free Cash Flow to Firm -4.196 Million
View SEC Filings from PETX instead.

View recent insider trading info

Funds Holding PETX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PETX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2019-07-18:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-07-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-06-07:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2019-05-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-04-26:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-03-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-01-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-01-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2018-12-28:
    Item 1.02: Termination of a Material Definitive Agreement
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    RAINES MERILEE

    • Director
    No longer subject to file 2019-07-18 0

    HOCKADAY IRVINE O JR

    • Director
    No longer subject to file 2019-07-18 0

    YARNO WENDY L

    • Director
    No longer subject to file 2019-07-18 0

    TOOMAN CRAIG A PRESIDENT AND CEO

    • Officer
    • Director
    No longer subject to file 2019-07-18 0

    ROCHE ROBERT P JR

    • Director
    No longer subject to file 2019-07-18 0

    ROBINSON LOWELL W

    • Director
    No longer subject to file 2019-07-18 0

    BRINKLEY DAVID L

    • Director
    No longer subject to file 2019-07-18 0

    VANDER VORT JOHN

    • Director
    No longer subject to file 2019-07-18 0

    BARBAROSH CRAIG A.

    • Director
    No longer subject to file 2019-07-18 0

    BROADFIN HEALTHCARE MASTER FUND LTD

    BROADFIN CAPITAL, LLC

    KOTLER KEVIN

    • 10% Owner
    No longer subject to file 2019-07-18 0

    HEINEN ERNST CHIEF DEVELOPMENT OFFICER

    • Officer
    No longer subject to file 2019-07-18 0

    READY CHRISTOPHER T VP OF SALES AND MARKETING

    • Officer
    No longer subject to file 2019-07-18 0

    AYRES JOHN C SEE REMARKS

    • Officer
    No longer subject to file 2019-07-18 0

    HELLUMS RHONDA LYNETTE CHIEF FINANCIAL OFFICER

    • Officer
    No longer subject to file 2019-07-18 0

    ST PETER STEVEN PRESIDENT AND CEO

    • Officer
    • Director
    603,623 2018-12-17 0

    BREGE LAURA

    • Director
    13,500 2018-07-27 0

    STANDRIDGE BRENT CHIEF OPERATING OFFICER

    • Officer
    99,967 2018-06-25 0

    GERBER ROBERT BENTHALL JR

    • Director
    24,042 2017-06-21 0

    STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER

    • Officer
    127,503 2016-06-28 0

    LICHTER JAY

    • Director
    2,374,568 2015-07-15 0

    RHODES LINDA CHIEF SCIENTIFIC OFFICER

    • Officer
    423,205 2015-04-24 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments